Life-Sciences-France.com
The French Life Sciences Web Portal

This is a free web portal for the life sciences in France and Monaco... » read more

Abalos Therapeutics Extends Series A with €32.5m to €43m (2021-10-14)
Additional EUR 32.5 million will support clinical readiness and accelerate lead immuno-virotherapy candidates toward clinical proof-of-concept Abalos Therapeutics announced today an extension to its Series A funding round bringing the total raised in this rou...
Pierre Fabre & Talem Tx: Antibody Discovery Research (2021-10-07)
Multi-target research collaboration leverages ImmunoPrecise’s powerful antibody discovery technologies with the long-standing expertise of Pierre Fabre in immuno-oncology IMMUNOPRECISE ANTIBODIES LTD. (the “Company” or “IPA”) (NASDAQ: IPA) (TSX VENTURE: IPA) a...
iOMx Therapeutics Raises €65m Series B Led by Athos & MIG (2021-10-05)
> Financing round with top-tier life science venture capitalists, led by Athos Service and MIG Capital, joined by existing shareholders > The new funds will be used to advance iOmx ´ lead programs IMT-07 and IMT-18, both addressing novel immune checkpoint targe...
Atara Biotherapeutics: Pierre Fabre to Commercialize Tab-cel (2021-10-04)
> Pierre Fabre to Commercialize Tab-cel® for Epstein-Barr Virus (EBV)-Positive Cancers in Europe, Middle East, Africa, and Other Select Emerging Markets > Atara to Receive Upfront Payment of USD 45 Million, and Up to Approximately USD 320 Million in Total Milest...
Aglaia Therapeutics Raises €4m Seed Round Led by Advent FB (2021-09-27)
> Venture capital firm Advent France Biotechnology led fundraising, alongside Crédit Mutuel Innovation and Pierre Fabre > Co-founded by AFB and leading cancer institutes Gustave Roussy and Institut Curie, startup will use funding to prepare essential preclinical...
Jeito Capital Closes European Life Sciences Fund at €534m (2021-09-20)
> Oversubscribed Jeito I becomes the largest European fund dedicated to the life sciences sector. > Jeito Capital is dedicated to working with biotech entrepreneurs to provide financial and expert support in continuity to accelerate patients’ access to groundbre...
TreeFrog: $75m Series B, New CEO, New Subs in USA & Japan (2021-09-13)
Frederic Desdouits, PhD, named chief executive officer. Co-founder Kevin Alessandri, PhD, relocates to Boston to drive TreeFrog Therapeutics’ expansion in the U.S. TreeFrog Therapeutics, a privately held French-based biotech startup focused on developing safe ...
Diaccurate Acquires Cancer Drug Candidate from Merck KGaA (2021-09-08)
> DIACC3010, formerly M2698, is a Phase II-ready dual PAM inhibitor with rare brain-penetration properties > Merck KGaA, Darmstadt, Germany, to become a shareholder of Diaccurate, remains fully committed to the success of the drug candidate > Diaccurate to s...
Forbion Appoints Nanna Lüneborg as a General Partner (2021-09-01)
- Brings extensive international investment and board experience in life sciences companies of all sizes including company creations, private venture deals and IPOs - Forbion, a leading European life sciences venture capital firm, today announces the appointme...
Tissium’s €50m Series C Led by Cathay Health & Sofinnova (2021-08-31)
TISSIUM, a privately-owned medtech company developing biomorphic programmable polymers for tissue reconstruction, announced it has closed a Series C round of financing, raising €50 million from new and existing international investors. Cathay Health, affiliated to ...

Life-Sciences-France.com is your doorway to the French life sciences!

[LSF] provides free, up-to-date and structured access to

– News
– Products
– Persons
– Organisations
– Financings
– Collaborations

in France and Monaco.

Access is unrestricted and free, requiring no log in and no user registration.The high-quality content is not related to the advertising, with topical relevance being the criterion for inclusion. [LSF] is 100% Made in Germany!

» Start here with the latest News!

Picture EBD Group Connector Personal Networking in Life Sciences 650x80

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)